Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSB2500107 | BNT323 | BNT-323 | Biological Products(1) | Supplementary Application | 2025-06-25 | BioNTech (Shanghai) Pharmaceuticals Co Ltd;Yingen Biopharmaceutical (Suzhou) Co Ltd | view | ||||
CXSL2500174 | BNT323 | BNT-323 | Biological Products(1) | New Drug Application | 2025-02-25 | Yingen Biopharmaceutical (Suzhou) Co Ltd | view | ||||
CXSL2400929 | BNT323 | BNT-323 | Biological Products(1) | New Drug Application | 2024-12-31 | BioNTech (Shanghai) Pharmaceuticals Co Ltd;Yingen Biopharmaceutical (Suzhou) Co Ltd | view |